SGIOF News and Press, Shionogi & Co Ltd From 02/01/21

The following slide deck was published by Shionogi & Co., Ltd. in conjunction with their 2021 Q3 earnings call. For further details see: Shionogi & Co., Ltd. 2021 Q3 - Results - Earnings Call Presentation

Shionogi & Co. (SGIOF): 9M GAAP EPS of ¥279.80.Revenue of ¥224.4B (-11.9% Y/Y)Press Release For further details see: Shionogi & Co. reports 9M results

The European Medicines Agency's advisory group CHMP has adopted positive opinions backing extended uses of the following drugs:Amgen's (AMGN) Kyprolis (carfilzomib): in combination with daratumumab and dexamethasone, with lenalidomide and dexamethasone or with dexamethasone alone for the trea...

The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval for Viiv Healthcare's Vocabria (cabotegravir injection and tablets) in combination with Rekambys (rilpivirine injection) and Edurant (rilpivirine tablets), for the treatment of HIV-1 infec...

Shionogi & Co. ( OTCPK:SGIOF ) : Q1 net income of ¥21.5B More news on: Shionogi & Co., Ltd., Shionogi & Co., Ltd., Earnings news and commentary, Healthcare stocks news, Read more ...

The following slide deck was published by Shionogi & Co., Ltd. in conjunction with their 2020 Q1 earnings Read more ...

ViiV Healthcare, majority owned by GSK, with Pfizer and Shionogi as shareholders, announced the FDA nod for Rukobia (fostemsavir), a human immunodeficiency virus type 1 gp120-directed attachment inhibitor, in combination with other antiretrovirals, for HIV-1 infection More news on: Glaxo...

A Phase 3 clinical trial, BLOCKSTONE , evaluating the ability of Roche's ( OTCQX:RHHBY ) Xofluza (baloxavir marboxil) to prevent a healthy person from contracting influenza from an infected family member met the primary endpoint . The results were presented at the OPTIONS X congress in S...

Sandoz has signed an agreement with Shionogi & Co Ltd ( OTCPK:SGIOF ) for commercialization of Rizmoic (naldemedine) in the key European markets of Germany, UK and Netherlands. More news on: Shionogi & Co., Ltd., Shionogi & Co., Ltd., Healthcare stocks news, Read more ......